Tracy M. Woody
Director/Board Member bei ESPERION THERAPEUTICS, INC.
Vermögen: 89 957 $ am 31.03.2024
Profil
Tracy M.
Woody is currently a Non-Executive Director at Shorla Pharma Ltd.
since 2020 and an Independent Non-Executive Director at Esperion Therapeutics, Inc. since 2019.
Previously, Ms. Woody held the position of Chief Executive Officer at Retroject, Inc. from 2013 to 2015.
Ms. Woody also worked as a Director at ALZA Corp.
Ms. Woody was the Managing Director at Tmw Consulting, Inc. from 2013 to 2015.
Ms. Woody served as a Senior Manager-Marketing at Pfizer Inc. Ms. Woody held the position of Vice President-Sales & Marketing at NextWave Pharmaceuticals, Inc. Ms. Woody was the Chief Commercial Officer at Zevra Therapeutics, Inc. from 2015 to 2016.
Ms. Woody also worked as the Vice President-Business Development at Greer Laboratories, Inc. Ms. Woody was the Executive Vice President-Commercial Strategy at Protagonist Therapeutics, Inc. from 2020 to 2022.
Ms. Woody served as the Chief Commercial Officer at Versartis, Inc. from 2017 to 2018.
Ms. Woody also held the position of Chief Commercial Officer at Aravive, Inc. from 2017 to 2018.
Ms. Woody obtained an undergraduate degree from East Carolina University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.06.2023 | 33 566 ( 0,02% ) | 89 957 $ | 31.03.2024 |
Aktive Positionen von Tracy M. Woody
| Unternehmen | Position | Beginn |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Director/Board Member | 01.05.2019 |
Shorla Pharma Ltd.
 Shorla Pharma Ltd. Pharmaceuticals: MajorHealth Technology Shorla Pharma Ltd. manufactures drugs in the oncology space for women’s and pediatric cancers. Its products include SH-111. The company was founded by Sharon Cunningham and Orlaith Ryan in 2018 and is headquartered in Clonmel, Ireland. | Director/Board Member | 10.11.2020 |
Ehemalige bekannte Positionen von Tracy M. Woody
| Unternehmen | Position | Ende |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Corporate Officer/Principal | 01.09.2022 |
| ARAVIVE, INC. | Corporate Officer/Principal | 12.10.2018 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | 12.10.2018 |
| ZEVRA THERAPEUTICS, INC. | Corporate Officer/Principal | 15.09.2016 |
Tmw Consulting, Inc.
 Tmw Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Tmw Consulting, Inc. provides business consulting services. | Chief Executive Officer | 01.02.2015 |
Ausbildung von Tracy M. Woody
| East Carolina University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| PFIZER, INC. | Health Technology |
| ESPERION THERAPEUTICS, INC. | Health Technology |
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Health Technology |
Greer Laboratories, Inc.
 Greer Laboratories, Inc. Medical/Nursing ServicesHealth Services Greer Laboratories, Inc. develops and provides allergy immunotherapy products and services for treating humans and animals. The company was founded in 1904 and is headquartered in Lenoir, NC. | Health Services |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
Tmw Consulting, Inc.
Tmw Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Tmw Consulting, Inc. provides business consulting services. | Commercial Services |
Retroject, Inc.
 Retroject, Inc. Medical SpecialtiesHealth Technology Retroject, Inc. manufactures surgical and medical instruments. | Health Technology |
Shorla Pharma Ltd.
Shorla Pharma Ltd. Pharmaceuticals: MajorHealth Technology Shorla Pharma Ltd. manufactures drugs in the oncology space for women’s and pediatric cancers. Its products include SH-111. The company was founded by Sharon Cunningham and Orlaith Ryan in 2018 and is headquartered in Clonmel, Ireland. | Health Technology |
